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In order to elucidate a part of calmodulin actions in 
the hyperproliferative state in human epidermis , cal-
modulin activities in the psoriatic and in the normal 
human epidermis were determined using calmodulin-
deficient phosphodiesterase from bovine heart and pur-
ified pig skin epidermal calmodulin as a standard. Skin 
samples were obtained from 11 normal healthy controls 
and from both the uninvolved and involved regions of 8 
nonconsanguineous psoriatic patients. Pure epidermal 
samples, prepared by the microdissection method, were 
used for calmodulin assays. Normal human epidermis 
contained 270 ± 13 ng/mg dry weight, whereas calmo-
dulin activities were significantly increased in psoriatic 
epidermis, 412 ± 29 ng/mg dry weight for the unin-
volved epidermis and 7 4 7 ± 46 ng/mg dry weight for 
the involved epidermis, respectively. These results sug-
gest that calmodulin may play an important role in cell 
proliferation in human epidermis. 
Calmodulin is known as a ubiquitous multifunctional cal-
cium-dependent protein present in the cytosol of a wide variety 
of eukaryotic cells. Recent reports have revealed that calmo-
du lin is involved in cell proliferation or cell division in several 
cell systems [1,2] . In addition, it was also observed that cal-
modulin levels were elevated in virally transformed cells [3,4) 
and neoplastic tissues of human mammary gland [5) and rat 
liver [6). 
Since t he demonstration of mouse epidermal calmodulin by 
Murray and Rogers in 1978 [7], its existence was a lso confirmed 
by pig skin [8] and human epidermis [9] . 
However , how epidermal calmodulin is implicated in the 
induction of the hyperproliferative and/or neoplast ic state in 
human epidermal keratinocytes remains obscure. Recently it 
was shown that calmodulin levels were markedly elevated, 
approximately 30 times in the psoriatic lesion as compared to 
the uninvolved and normal epidermis [10) . Although this ob-
servation was later supported by Tucker et al [11], according 
to their data it was indicated that uninvolved epidermis in 
psoriasis contained somewhat higher amounts of calmodulin as 
compared to those in involved epidermis. In contrast with these 
observations, our previous data have shown that no critical 
difference of its activities was observed in either involved or 
uninvolved epidermis in psoriasis [12] . A possible reason for 
this discrepancy is that we used a Castroviejo keratome in the 
previous study to obtain epidermal samples as assay materials. 
This study was undertaken to resolve this discrepancy, by 
using pure epidermal samples, prepared by the microdissection 
method. 
MATERIALS AND METHODS 
Purification of pig skin epidermal calmodulin has been reported 
elsewhere [8,13]. Calmodulin -deficient phosphodieste rase was prepared 
from bovine heart as previously described [8]. 
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Skin samples for calmodulin determination were obtained from 
various sites from 11 normal healthy volunteers without any skin 
diseases (ages varied from 8-83 years) and 8 nonconsanguineous pso-
riatic patients (ages varied from 39-64 years) by excision biopsies under 
local anesthesia, using 0.5% lidocaine with no addition of epinephrine 
(Fujisawa Pharmaceutical Co. Osaka, J apan) . All the skin specimens 
of psoriatic patients were taken from both plaque and uninvolved skin 
(5 em distance from plaque). Each skin sample t hus obtained was 
immediately frozen in liquid ni t rogen and sliced at 16 I'm thickness in 
the cryostat, set at - 25"C, and then freeze-dried overnight with the 
lyophilizer. The horny layer and dermal constituent of these freeze-
dried skin slices were removed under the stereomicroscope to provide 
pure epidermal samples for the calmodulin measurement as was pre-
cisely described previously by Adachi and Yamasawa [14]. The weight 
of these pure epidermal samples was measured by means of the quartz 
microbalance. 
The procedure of calmodulin assay was essentially identical with the 
method described by Teo et al [15], using calmodulin-deficient phos-
phodiesterase from bovine heart and pig skin epidermal calmodulin as 
a standard. Each assay was performed in triplicate. Statistical analysis 
of the data was carried out by Student's t-test. Cyclic AMP and 5'-
nucleotidase grade UI from Crotalus adaman.teu.s were obtained from 
Sigma Chemical Co. (St. Louis, Missouri) . All other chemicals were of 
analytical grade and were purchased from Nakarai Chemicals, Ltd. 
(Kyoto, Japan). 
RESULTS 
Calmodulin prepared from pig skin epidermis migrated as a 
single band on sodium dodecyl sulfate-polyacrylamide gel elec-
trophoresis and molecular weight was estimated at approxi-
mately 16,500- 17,500 (data not shown). As can be seen in Fig 
1, calmodulin-deficient phosphodiesterase prepared from bo-
vine heart was activated by the purified epidermal calmodulin 
in the presence of calcium. 
Calmodulin activities in individua l skin samples were as 
follows. In normal human epidermis, calmodulin activity was 
270 ± 13 ng/mg dry weight. In contrast to this, its activities 
were much higher in both the uninvolved and involved epider-
mis of psoriasis. It was shown to be 412 ± 29 ng/mg dry weight 
for the uninvolved epidermis (p < 0.001 when compared with 
normal human epidermis) and 747 ± 46 ng/mg dry weight for 
the involved epidermis (p < 0.001 when compared with t he 
uninvolved epidermis) (Fig 2). 
DISCUSSION 
As mentioned previously, it has been shown by several au-
thors [10,11] that calmodulin may play an important role in 
the induction of its hyperproliferative state in psoriatic epider-
mis. According to these reports, although calmodulin activities 
were elevated in the involved epidermis in psoriasis, there was 
a great difference in its activities in the uninvolved epidermis 
in psoriasis. While Van de Kerkhof and Van Erp reported that 
calmodulin levels were increased more than 30 times in the 
psoriatic lesion in comparison with those in normal and unin-
volved epidermis [10], Tucker et a! found that increases of 
calmodulin levels were approximately 6-8 times in both unin-
volved and involved epidermis in psoriasis as compared to 
normal counterparts [ll]. According to our previous study, 
however, there were no significant differences in calmodulin 
activities between involved and uninvolved epidermis in pso-
riasis, when a Castroviejo keratome was used to obtain epider-
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FIG 1. Standard curve of calmodu lin assay for calmodulin-deficient 
cAMP phosphodiesterase. Standard assays were performed at pH 7.5 
and 30' C for 80 min. The reaction mixtures of 0.5 ml contained, in 
addition to 50 l'l of the phosphodiesterase and various amounts of pig 
sk in epidermal calmodulin (abscissa) , 60 mM each ofTris and imidazol, 
6 mM magnesium acetate, 2 mM cAMP, 50 !JM calcium chloride, and 
0.2 units of 5' -nucleotidase. Inorgan ic phosphate released was deter· 
mined as previously described [8) . Each point denotes a mean of 
duplicate assays. The arrow indicates 0 va lue. 
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F I C: 2. Calmodulin activities in the normal human and the psoriatic 
epidermis (uninvolved and involved). Each point denotes a mean of 
triplicate assays of individual skin samples. 
mal assay materials [12]. As a possible explanation for t he 
inconsistent values of calmodulin levels in the involved and 
uninvolved psoriatic epidermis found by these investigators, 
aside from the methodologic differences of calmodulin assay, it 
could be assumed to be due to the difference in skin samples 
examined. When skin samples were taken with a Castroviejo 
keratome or razor blade, a certain dermal contamination could 
not be avoided. Therefore, the microdissection method was 
employed in the present study in order to obtain pure epidermal 
samples. Similar evidence had already been presented by Iizuka 
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et al (16) in the cyclic nucleotide-phosphodiesterase assay in 
psoriasis. 
By using pure epidermal samples thus obtained, it was shown 
that calmodulin activities in the uninvolved and involved epi-
dermis in psoriasis were increased as compared to t hose of 
normal human epidermis (Fig 2). It should be reemphasized 
from our data, that in determining the biologically active sub-
stances in epidermal keratinocytes, one should use pure epider-
mal samples as t he analytical materials. 
Although most of the epidermal phosphodiesterase is not 
regulated by calmodulin (8], in recent years the biologic role of 
calmodulin on the cell cycle has been suggested [2,17). Even if 
our data of increased calmodulin activities in psoriatics are 
consistent with those assumptions, their precise interrelation 
remains unknown. In this connection, it is suggested that 
calmodulin might also play an appreciable role in the regulation 
of its cellular biologic process in human epidermal keratino-
cytes. 
From the present results, we would like to draw the following 
conclusions: (1) normal human epidermis contains a significant 
amount of biologically active calmodulin, as was suggested by 
Peterson and Wuepper [9]; (2) psoriatic epidermis (both the 
uninvolved and involved) has higher activities of calmodulin 
than normal human epidermis; (3) calmodulin may also partic-
ipate in the initiation of the hyperproliferative state of human 
epidermal keratinocytes, as was suggested in psoriasis. 
Addendum 
During the revision of this manuscript, Fairley et al reported 
an excellent study on calmodulin levels in normal and psoriatic 
epidermis (J Invest Dermatol 84:195- 198, 1985). Their data 
were fundamentally coincident with our findings in this man-
uscript. 
We are grateful to MissY. Abe and Mrs. M. Ueno for their excellent 
technica l assistance. We a lso wish to thank Miss A. Naeka for her help 
in preparing this manuscript . 
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